Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Alopecia Areata might be linked to Crohn's disease.

Alopecia areata requires early, personalized treatment for hair loss and mental health, with promising new therapies needing more research.

Toll-like receptor 3 helps repair the skin barrier after UV damage.

SLE patients experience hair loss similar to telogen effluvium, with hair damage and immune activity at hair follicles.

Hair loss, known as androgenetic alopecia, is mainly caused by genetics, but also by hormone imbalances, shrinking hair follicles, inflammation, and environmental factors.

Tretinoin may help some who don't respond to minoxidil alone, but it's not a first choice due to possible irritation.

Photobiomodulation therapy shows promise in treating various health conditions by using specific light wavelengths.

Non-scarring hair loss in lupus patients often responds well to treatment and doesn't lead to scarring.

A witch-hazel-based 5% minoxidil solution is effective and safe for women with hair loss who didn't respond to regular minoxidil, especially if they're sensitive to propylene glycol.

A 50 mg non-loading dose of ritlecitinib is safe for adults and adolescents.

Calreticulin has roles in healing, immune response, and disease beyond its known functions in the endoplasmic reticulum.

Mitochondria may influence how cells respond to radiation, affecting nearby non-irradiated cells.

ATR-FTIR spectroscopy could help monitor alopecia areata treatment response non-invasively.

SARS-CoV-2 proteins help the virus avoid the immune system, delaying response and increasing inflammation.

Sintilimab with chemotherapy improves survival and response in advanced lung cancer but increases some side effects.

The new chemotherapy combination for advanced lung cancer showed a 35.7% response rate but caused significant side effects.

NSAIDs may not affect soft tissue healing but should be used carefully for bone fractures and more research is needed to understand sex differences in response.

New treatments for non-small cell lung cancer are being tested, with some already in use, focusing on immune response and targeting cancer cells, but side effects vary.

The treatment showed high response rates and was well-tolerated, potentially extending patient survival.

Acne patients' skin, both with and without lesions, shows a strong immune response and higher antimicrobial activity.

The document suggests that severe hair loss in SLE patients may be an early sign of scalp DLE, treatable with immunosuppressive therapy.

Kerion cases had longer disease duration but responded well to antifungal treatments.

Kang-ai injection with platinum-based chemotherapy improves tumor response and immune function while reducing side effects in advanced lung cancer.

CTA is often mistaken for AA but doesn't respond to steroids and may require hair transplantation.

Advancements in nanoformulations for CRISPR-Cas9 genome editing can respond to specific triggers for controlled gene editing, showing promise in treating incurable diseases, but challenges like precision and system design complexity still need to be addressed.

Vellus hair cysts can cause acne-like bumps that don't respond to treatment.

Wrinkles form due to structural skin changes and vary in type and treatment response.

Proxalutamide improved blood markers related to inflammation, immune response, and clotting in COVID-19 patients, potentially reducing hospitalizations.

The U.K. created the CPSA to set safety standards for non-surgical cosmetic treatments and improve patient protection.

Early diagnosis and tailored treatment improve outcomes for non-nutritional rickets.